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Aims:   To assess the safety of Bifidobacterium pseudocatenulatum G4 in BALB/c mice that 
involves examination of bacterial translocation, changes in the internal organs and histology 
of the intestinal lining. Methods and Results:  Forty male BALB/c mice were randomly 
assigned into five groups (n = 8). Three groups were orally fed with 50 μl of three different 
concentrations of B. pseudocatenulatum G4 (2 × 104, 1 × 108 and 1 × 1011 CFU day−1) for 
4 weeks. One group was orally administered with 50 μl of 1 × 108 CFU B. longum BB536 
per day for 4 weeks and last group was used as a nonbifidobacterial treatment control, which 
received 50 μl of skim milk. The administered strains did not affect the general health of mice 
and incapable of carrying out translocation to blood or liver. There were no significant 
differences in the internal organ (liver, heart, kidney and spleen) indices, serum enzymes of 
liver (aspartate aminotransferase, alkaline phosphate, alanine aminotransferase) and kidney 
(urea and creatinine) and histology (villi height, crypts height, mucosa thickness and 
epithelial cell height) of caecum, ileum and colon. Conclusion:  Administration of high dose 
of up to 1 × 1011 CFU B. pseudocatenulatum G4 per day to mice did not show any health 
threatening symptoms. Significance and Impact of the Study: Bifidobacterium 
pseudocatenulatum G4 is none pathogenic to BALB/c mice and could be safe probiotic for 
human consumption. 
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